COVID-19 Information: Learn more.

Ric Scalzo Institute for

Botanical Research

In July of 2020, SCNM began expansion of the Ric Scalzo Institute for Botanical Research with the construction of a state-of-the-art molecular biology/phytochemistry laboratory. The Institute is working in collaboration with the natural products industry and other institutions to develop new products and improve existing botanical therapeutics through scientific exploration grounded in clinical herbalism’s rich tradition. The Ric Scalzo Institute for Botanical Research will carry multiple laboratory facilities including a Biosafety Level 2 (BSL2) molecular and cellular biology laboratory with cell/virus culture capabilities, a compound isolation laboratory, and a compound identification and quantification facility.

Interested in learning more or working with the Ric Scalzo Institute? Contact


The Institute’s mission is “Inspired by nature to create novel botanical solutions that support people, planet, and plants.”

Inside The Lab

What factors need to be understood to assess a botanical’s medicinal potential?

Botanical formulations present challenges for rigorous scientific testing to understand their actual therapeutic efficacy.

To assess a botanical’s medicinal potential, two factors need to be understood:

  • The chemical composition, stability, and consistency across manufacturing batches
  • The botanical’s mechanism of action within a cell and the body.

What will be considered when the Institute evaluates the potential of a botanical research project?

  • The current state of knowledge of the botanical is evaluated related to traditional/historical therapeutic activity
  • Relevant scientific literature published
  • Accessibility of in vitro bioassay systems available

What will occur after the evaluation?

Once assessed, valid plant material is obtained and tested for basic biological activity. This in vitro system will be optimized and modified to develop a consistent and reliable method to evaluate and/or validate the biological activity of a specific botanical. From this, optimal extraction, concentration and delivery methods can be developed, pilot clinical trials performed, and further deciphering of the specific mechanism of action of the botanical completed.

In addition, through bioassay-guided fractionation and purification, the constituent profile of a botanical can be used to standardize botanical therapies and the active therapeutic compound(s) isolated and identified.

What will this analysis be used for?

By combining this in-depth analysis of botanicals, novel synergistic botanical blends can be designed and traditional formulas can be optimized to target different aspects of a disease. Thus, the therapeutic claims can be validated, as well as herbal product standardization and quality control can be performed to develop evidence-based, standardized natural products.